期刊文献+

匹伐他汀调脂临床研究进展 被引量:5

下载PDF
导出
出处 《中南药学》 CAS 2008年第2期226-229,共4页 Central South Pharmacy
  • 相关文献

参考文献30

  • 1[1]Shepherd J,Blauw GJ,Murphy MB,et al.Pravastatin in elderly individuals at risk of vascular disease(PROSPER):A randomised controlled trial[J].Lancet,2002,360(9346):1623-1630.
  • 2[2]Cannon CP,Braunwald E,McCabe CH,et al.Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators.Intensive versus moderate lipid lowering with statins after acute coronary syndromes[J].N EnglJ Med,2004,350(15):1495-1504.
  • 3[3]Bolego C,Poll A,Cignarella A,et al.Novel statins:Pharmacological and clinical results[J].Cardiovase Drugs Ther,2002,16(3),251-257.
  • 4[4]Saito Y,Yamada N,Teramoto T.et al.Clinical efficacv of pitavastatin,a new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor,in patients with hyperlipidemia.Dose finding study using the double-blind,three-group parallel comparison[J].Arzneimittelforschung,2002,52(4):251-255.
  • 5[5]Bolego C,Baetta R,Bellosta S,et al.Safety considerations for statins[J].Curr Opin Lipidol,2002,13(6):637-644.
  • 6[6]Kajinami K,Takekoshi N,Saito Y.Pitavastatin.Efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor[J].Cardiovasc Drug Rev,2003,21(2):199-215.
  • 7[7]Kojima J,Fujino H,Yosimura M,et al.Simultaneous determination of NK-104 and its lactone in biological samples by colurnn-switching high-performance liquid chromatography with ultraviolet detection[J].J Chromatogr B Biomed Sd Appl,1999,724(1),173-180.
  • 8[8]Fujino H,Kojina J,Yamada Y,et al.Studies on thc metabolic fate of NK-104,a new inhibitor of HMG-CoA reductase(4):Interspecies variation in laboratory animals and humans[J].Xenobiol Metab Dispos,1999,14(2):79-81.
  • 9[9]Garcia MJ,Reinoso RF,Navarro AS,et al.Clinical pharmaeokinetics of statins[J].Methods Find Exp Clin Pharmacol,2003,25(6):457-481.
  • 10[10]Kajinami K,Mabuchi H,Saito Y.NK-104:A novcl synthetic HMG-COA reduetase inhibitor[J].Expert Opin Invest Drugs,2000,9(11):2653-2661.

同被引文献22

  • 1何笑荣,邹定,姜文清,马捷,李金娥.降血脂新药匹伐他汀[J].中国新药杂志,2005,14(4):483-487. 被引量:32
  • 2林玲,罗燕,彭玉兰,周东.彩色多普勒超声对脑梗死患者颈动脉病变的研究[J].中华老年心脑血管病杂志,2005,7(3):175-177. 被引量:31
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 4Mukhtar R Y A,Reid J P,Reckless J P D.Pitavastatin[J].Int J Clin Pract,2005,59(2):239-252.
  • 5Bolego C,Poli A,Cignarella A,et al.Novel statins:pharmacological and clinical results[J].Cardiovasc Drugs Ther,2002,16(3):251-257.
  • 6Bolego C,Baetta R,Bellosta S,et al.Safety considerations for statins[J].Curr Opin Lipidol,2002,13(6):637-644.
  • 7周书明,尹秋生,曹少军,姚依群,周茂林,陆建国.1281例老年人心血管疾病危险因素综合干预的效果[J].中华老年心脑血管病杂志,2007,9(10):671-673. 被引量:34
  • 8Afilalo J,Duque G,Steele R,et al.Statins for secondary prevention in elderly patients:a hierarchieal Bayesian meta-analysis[J].J Am Coll Cardiol,2008,51(1):37-45.
  • 9Baigent C,Keech A,Kearney PM,et al.Efficacy and safety of cholesterol-lowering treatment:prospective meta-analysis of data from 90 056 participants in 14 randomized trials of statins[J].Lancet,2005,366(9493):1267-1278.
  • 10Tkuno A,Hirano T,Hayashi T,et a1.The effects of statin and fibrate on lowering small dense LDL-cholesterol in hyperlipidemic patients with type 2 diabetes[J].J Atheroscler Thromb,2007,14(3):128-132.

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部